Redesigning obesity trials for a chronic disease era
For much of its history, obesity research has occupied an awkward space within clinical development. Too medical to dismiss outright, yet, too entangled with lifestyle narratives to command the same seriousness as closely linked conditions like cardiovascular disease or diabetes, it has often been studied through a narrow lens – short trials, blunt endpoints, and a lingering assumption that weight loss alone was the outcome that mattered.
Industry Events & Conferences
SaxoCell Conference on Cell and Gene Therapy
Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...
11th German Pharm-Tox Summit 2026
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...
BIO International Convention
hVIVO is proud to be attending BIO International Convention 2026, the world’s largest gathering of biotechnology, ...
World Vaccine Congress Europe
Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World Vaccine Congress ...
BIO-Europe 2026
Connect with the Right Partners to Accelerate Biopharma Growth hVIVO will be attending BIO-Europe, the leading ...
Dutch Life Sciences Conference 2026
Connect with Europe’s Leading Life Sciences Ecosystem hVIVO will be attending the Dutch Life Sciences Conference, a key ...
Hands On Workshops
Workshop: Build Your Target Product Profile With Confidence
Build your Target Product Profile With Confidence For biotech and start‑up teams balancing innovation with speed, a ...
From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
A case-based, interactive workshop designed to equip participants with the tools needed to navigate the path to ...
On-Demand Education
.jpg)
Accelerate your RSV Programme with our RSV Human Challenge Model
About RSV & why developing RSV antivirals and vaccines are critical Respiratory Syncytial Virus (RSV) is a common, ...
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Technical Due Diligence in Drug Development: What Startup Founders Need to Know to Succeed
Join industry experts for an interactive discussion on mastering technical due diligence. Due diligence is a critical ...
Upcoming Live Webinars
The future of cardiometabolic trials: From obesity to outcomes that matter
As obesity continues to reshape the cardiometabolic landscape, early-stage developers face growing pressure to generate ...
News & Resources
MAPLE‑UK: Redefining Airway Disease Research for the Real World
MAPLE‑UK: Unlocking New Pathways for Respiratory Therapies
.png)
Fast‑Tracking First‑in‑Human: Five Lessons Startups Can’t Afford to Miss
The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose
What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them
Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs
Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
Why are Biotech’s & Pharma Using Human Challenge Studies for Drug Development?
Tripledemic Takedown: How Human Challenge Trials are Ideal to Expedite Multivalent Vaccine Development